Liora M. Schultz

4.5k total citations
41 papers, 455 citations indexed

About

Liora M. Schultz is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Liora M. Schultz has authored 41 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Liora M. Schultz's work include CAR-T cell therapy research (33 papers), Acute Lymphoblastic Leukemia research (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Liora M. Schultz is often cited by papers focused on CAR-T cell therapy research (33 papers), Acute Lymphoblastic Leukemia research (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Liora M. Schultz collaborates with scholars based in United States, Israel and France. Liora M. Schultz's co-authors include Holbrook E. Kohrt, Aurélien Marabelle, Roch Houot, Crystal L. Mackall, Rebecca Gardner, Kara L. Davis, Debra K. Czerwinski, Ronald Levy, Everett Meyer and Crystal L. Mackall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Liora M. Schultz

32 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liora M. Schultz United States	10	347	202	132	77	73	41	455
Mingzhi Zhang China	9	334 1.0×	165 0.8×	110 0.8×	78 1.0×	79 1.1×	19	432
Yvette Bernal United States	11	375 1.1×	135 0.7×	142 1.1×	117 1.5×	67 0.9×	22	459
Jiazhen Cui China	11	312 0.9×	118 0.6×	139 1.1×	76 1.0×	79 1.1×	39	423
Elizabeth Veloso United States	5	281 0.8×	215 1.1×	97 0.7×	89 1.2×	44 0.6×	13	420
Martín Bonamino Brazil	12	233 0.7×	171 0.8×	139 1.1×	74 1.0×	32 0.4×	27	460
Fengtao You China	9	575 1.7×	473 2.3×	116 0.9×	134 1.7×	69 0.9×	17	651
Xue Lin United States	6	441 1.3×	138 0.7×	160 1.2×	120 1.6×	147 2.0×	10	516
Xiaoqian Liang China	6	243 0.7×	98 0.5×	117 0.9×	68 0.9×	54 0.7×	8	334
Chenggong Li China	12	399 1.1×	106 0.5×	247 1.9×	121 1.6×	106 1.5×	36	566
Sascha Haubner Germany	9	393 1.1×	263 1.3×	207 1.6×	97 1.3×	50 0.7×	16	614

Countries citing papers authored by Liora M. Schultz

Since Specialization

Citations

This map shows the geographic impact of Liora M. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liora M. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liora M. Schultz more than expected).

Fields of papers citing papers by Liora M. Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liora M. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liora M. Schultz. The network helps show where Liora M. Schultz may publish in the future.

Co-authorship network of co-authors of Liora M. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Liora M. Schultz. A scholar is included among the top collaborators of Liora M. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liora M. Schultz. Liora M. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lamble, Adam J., Sandra D. Bohling, Kara L. Davis, et al.. (2025). Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement. HemaSphere. 9(11). e70247–e70247.

McNerney, Kevin O. & Liora M. Schultz. (2025). Tisagenlecleucel in Practice: Real-World Lessons in Pediatric and Young Adult B-ALL. Transplantation and Cellular Therapy. 31(6). 351.e1–351.e11.

Zhang, Amy, Kara L. Davis, Sneha Ramakrishna, et al.. (2025). Establishing Concordance of Next Generation Sequencing and Flow Cytometry Measures of B-Cell Recovery Post-CAR T Cell Therapy in B-ALL. Transplantation and Cellular Therapy. 31(2). S205–S206.

Kim, Hyun Gi, Kristen W. Yeom, Zahra Shokri Varniab, et al.. (2025). Brain MRI changes in children and young adults with B-cell acute lymphoblastic leukemia following chimeric antigen receptor T-cell therapy. European Radiology. 35(9). 5206–5216. 1 indexed citations

Srinagesh, Hrishikesh K., Anne Marijn Kramer, John H. Baird, et al.. (2025). Clinical and Cytokine Features of Immune Effector Cell–Associated Hemophagocytic Lymphohistiocytosis–Like Syndrome. Blood Cancer Discovery. 7(2). 225–233.

McNerney, Kevin O., Caroline Diorio, Colleen Annesley, et al.. (2025). Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers. Transplantation and Cellular Therapy. 32(2). 158–168. 1 indexed citations

Kim, Hyun Gi, Courtney Erickson, Christina Baggott, et al.. (2025). Impact of CAR T cell therapy on thymus size in children and young adults with acute lymphoblastic leukemia. Scientific Reports. 15(1). 30360–30360.

Steineck, Angela, Elad Jacoby, Allison Barz Leahy, et al.. (2025). Access to CARe: A Narrative of Real‐World Medical Decision‐Making to Access Chimeric Antigen Receptor (CAR) T‐Cell Therapy in Children, Adolescents, and Young Adults. Pediatric Blood & Cancer. 72(4). e31516–e31516.

Capitini, Christian M., Amy Moskop, Anant Vatsayan, et al.. (2024). Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Advances. 8(15). 4164–4168. 2 indexed citations

10.

Maaskant, Janneke J., Karmella A. Haynes, Heather Lin, et al.. (2024). Obesity Attenuates CAR T-Cell Function in Pediatric B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4807–4807.

11.

Schultz, Liora M., et al.. (2023). Rational Alternatives to Fludarabine and Cyclophosphamide-Based Pre-CAR Lymphodepleting Regimens in the Pediatric and Young Adult B-ALL Setting. Current Oncology Reports. 25(8). 841–846. 6 indexed citations

12.

McNerney, Kevin O., Amy Moskop, Lena E. Winestone, et al.. (2023). Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 30(1). 75.e1–75.e11. 4 indexed citations

13.

Schultz, Liora M., Elad Jacoby, Adam J. Lamble, et al.. (2023). Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium. Transplantation and Cellular Therapy. 29(10). 592–593. 2 indexed citations

14.

Ligon, John A., Sneha Ramakrishna, Francesco Ceppi, et al.. (2023). INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies—Established Findings and Future Priorities. Transplantation and Cellular Therapy. 30(2). 155–170. 2 indexed citations

15.

Myers, Regina M., Elad Jacoby, Michael A. Pulsipher, et al.. (2023). INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 29(10). 598–607. 5 indexed citations

16.

Schultz, Liora M., Kara L. Davis, Christina Baggott, et al.. (2023). Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. Journal for ImmunoTherapy of Cancer. 11(2). e004851–e004851.

17.

Reschke, Agnes, Rebecca M. Richards, Stephanie M. Smith, et al.. (2022). Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. Frontiers in Oncology. 12. 1033993–1033993. 2 indexed citations

18.

Shyr, David C., Bing Zhang, Liora M. Schultz, et al.. (2020). HLA-haplotype loss after TCRαβ/CD19-depleted haploidentical HSCT. Bone Marrow Transplantation. 56(3). 733–737. 7 indexed citations

19.

Narayan, Rupa, Niclas Olsson, Lisa E. Wagar, et al.. (2019). Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin. PLoS ONE. 14(7). e0219547–e0219547. 34 indexed citations

20.

Houot, Roch, Liora M. Schultz, Aurélien Marabelle, & Holbrook E. Kohrt. (2015). T-cell–based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition. Cancer Immunology Research. 3(10). 1115–1122. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact